A Phase II Trial of Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Oxaliplatin (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 May 2011 Actual end date (October 2010) added as reported by ClinicalTrials.gov.
- 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2008 Status changed from recruiting to active, no longer recruiting.